CONGRESS ASSET MANAGEMENT CO

Position in TNGX — Tango Therapeutics, Inc.

CIK 897378 BOSTON, MA

Position in TNGX

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$11,902,119

+$4,760,847 QoQ

Shares Held

380,746

+11.5% QoQ

Ownership

0.263%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

of 8 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 88.36494670988007.ToString("F0")% Shared 0.ToString("F0")% None 11.635053290119922.ToString("F0")%

Healthcare · as of Jun 30, 2026

CONGRESS ASSET MANAGEMENT CO holds $715,705,658 across 14 Biotechnology names. TNGX ranks #7 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc	659,911	$208,591,267
2	TGTX	Tg Therapeutics, Inc.	2,600,123	$142,850,757
3	VCEL	Vericel Corp	2,916,295	$129,745,964
4	HALO	Halozyme Therapeutics, Inc.	1,229,106	$96,202,126
5	ALNY	Alnylam Pharmaceuticals, Inc.	265,701	$79,983,972
6	KRYS	Krystal Biotech, Inc.	40,134	$14,916,603
7	TNGX	Tango Therapeutics, Inc. This page	380,746	$11,902,119
8	RLAY	Relay Therapeutics, Inc.	626,141	$11,715,098

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,902,119	380,746	+11.5%	Shares	Sole	2026-07-07
2026-03-31	$7,141,272	341,361	+45.5%	Shares	Sole	2026-04-14
2025-12-31	$2,078,804	234,628	+2.9%	Shares	Sole	2026-01-09
2025-09-30	$1,916,208	228,120	+0.4%	Shares	Sole	2025-10-10
2025-06-30	$1,163,233	227,194	-0.1%	Shares	Sole	2025-07-16
2025-03-31	$311,484	227,361	-0.3%	Shares	Sole	2025-04-11
2024-12-31	$704,486	227,989	+9.0%	Shares	Sole	2025-01-30
2024-09-30	$1,609,839	209,070	-1.0%	Shares	Sole	2024-10-28
2024-06-30	$1,811,838	211,170	—	Shares	Sole	2024-08-02
No filing history on record for this holder in this stock.